Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Heart Journal|November 9, 2016
A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 studyLuca A Ferri, Nuccia Morici, Daniele Grosseto, et al.CJC Open|July 23, 2020
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary SyndromeNuccia Morici, Gianfranco Alicandro, Luca A Ferri, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 2, 2020
Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: insights from the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Stefano Savonitto, et al.JACC. Cardiovascular Interventions|September 22, 2014
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS studyTullio Palmerini, Paolo Calabrò, Federico Piscione, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 5, 2020
Impact of body mass index on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: Insights from the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Stefano Savonitto, et al.The American Journal of Medicine|November 18, 2018
Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionNuccia Morici, Stefano Savonitto, Luca A Ferri, et al.International Journal of Cardiology|July 30, 2022
Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trialGiuseppe De Luca, Monica Verdoia, Nuccia Morici, et al.Circulation|February 21, 2018
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous RevascularizationStefano Savonitto, Luca A Ferri, Luigi Piatti, et al.Expert Review of Medical Devices|September 15, 2023
Bridging the gap in the symptomatic heart failure patient journey: insights from the Italian scenarioMatteo Ziacchi, Alberto Spadotto, Stefano Ghio, et al.Pageof 3